KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) EBIT (2016 - 2025)

Historic EBIT for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $137.4 million.

  • Globus Medical's EBIT rose 18558.98% to $137.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $370.8 million, marking a year-over-year increase of 22005.35%. This contributed to the annual value of $166.0 million for FY2024, which is 2467.22% up from last year.
  • Globus Medical's EBIT amounted to $137.4 million in Q3 2025, which was up 18558.98% from $76.1 million recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's EBIT peaked at $137.4 million during Q3 2025, and registered a low of $404000.0 during Q3 2023.
  • Moreover, its 5-year median value for EBIT was $54.0 million (2022), whereas its average is $53.1 million.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 9932.33% in 2023, then surged by 1180544.55% in 2024.
  • Over the past 5 years, Globus Medical's EBIT (Quarter) stood at $18.2 million in 2021, then skyrocketed by 196.86% to $54.0 million in 2022, then tumbled by 81.26% to $10.1 million in 2023, then skyrocketed by 495.42% to $60.3 million in 2024, then surged by 127.9% to $137.4 million in 2025.
  • Its EBIT was $137.4 million in Q3 2025, compared to $76.1 million in Q2 2025 and $97.0 million in Q1 2025.